What is the share price of Boston Bio Systems Ltd (BOSTONBIO) today?
The share price of BOSTONBIO as on 11th July 2025 is ₹7.30. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Boston Bio Systems Ltd (BOSTONBIO) share?
The past returns of Boston Bio Systems Ltd (BOSTONBIO) share are- Past 1 week: -1.51%
- Past 1 month: -2.45%
- Past 3 months: -20.31%
- Past 6 months: -63.24%
- Past 1 year: -63.24%
- Past 3 years: N/A%
- Past 5 years: -63.24%
What are the peers or stocks similar to Boston Bio Systems Ltd (BOSTONBIO)?
The peers or stocks similar to Boston Bio Systems Ltd (BOSTONBIO) include:What is the market cap of Boston Bio Systems Ltd (BOSTONBIO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Boston Bio Systems Ltd (BOSTONBIO) is ₹5.11 Cr as of 11th July 2025.What is the 52 week high and low of Boston Bio Systems Ltd (BOSTONBIO) share?
The 52-week high of Boston Bio Systems Ltd (BOSTONBIO) is ₹20.10 and the 52-week low is ₹6.53.What is the PE and PB ratio of Boston Bio Systems Ltd (BOSTONBIO) stock?
The P/E (price-to-earnings) ratio of Boston Bio Systems Ltd (BOSTONBIO) is -9.29. The P/B (price-to-book) ratio is 0.79.Which sector does Boston Bio Systems Ltd (BOSTONBIO) belong to?
Boston Bio Systems Ltd (BOSTONBIO) belongs to the Financials sector & Investment Banking & Brokerage sub-sector.How to buy Boston Bio Systems Ltd (BOSTONBIO) shares?
You can directly buy Boston Bio Systems Ltd (BOSTONBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Boston Bio Systems Ltd
BOSTONBIO Share Price
7.301.81% (+0.13)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
BOSTONBIO Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
BOSTONBIO Performance & Key Metrics
BOSTONBIO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -9.29 | 0.79 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 17.16 | 2.48 | 1.02% |
BOSTONBIO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
BOSTONBIO Company Profile
Boston Bio Systems Ltd is engaged in trading of shares
360ONE
PE Ratio
47.54
47.54
1Y Return
23.26%
23.26%
Buy Reco %
90.00
90.00
PE Ratio
15.01
15.01
1Y Return
17.68%
17.68%
Buy Reco %
0.00
0.00
ANGELONE
PE Ratio
20.70
20.70
1Y Return
21.16%
21.16%
Buy Reco %
85.71
85.71
IIFL
PE Ratio
58.30
58.30
1Y Return
4.29%
4.29%
Buy Reco %
100.00
100.00
JMFINANCIL
PE Ratio
19.49
19.49
1Y Return
79.88%
79.88%
Buy Reco %
0.00
0.00
BOSTONBIO Forecast
BOSTONBIO Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
BOSTONBIO
BOSTONBIO
Income
Balance Sheet
Cash Flow
Annual Normal View
BOSTONBIO Income Statement
BOSTONBIO Income Statement
Annual Normal View
| Financial Year | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.19 | 0.19 | |||||
Raw Materials | 0.00 | 0.00 | 0.14 | 0.74 | 0.74 | |||||
| Power & Fuel Cost | ||||||||||
| Employee Cost | ||||||||||
| Selling & Administrative Expenses | ||||||||||
| Operating & Other expenses | ||||||||||
EBITDA | 0.00 | 0.00 | -0.14 | -0.55 | -0.55 | |||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||
| PBIT | 0.00 | 0.00 | -0.14 | -0.55 | -0.55 | |||||
| Interest & Other Items | — | — | — | — | — | |||||
| PBT | 0.00 | 0.00 | -0.14 | -0.55 | -0.55 | |||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||
| Net Income | 0.00 | 0.00 | -0.14 | -0.55 | -0.55 | |||||
| EPS | 0.00 | 0.00 | -0.20 | -0.78 | -0.79 | |||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Payout ratio | — | — | 0.00 | 0.00 | 0.00 |
BOSTONBIO Company Updates
FY 2023FY 2023
FY 2022FY 2022
FY 2021FY 2021
FY 2020FY 2020
FY 2019FY 2019
BOSTONBIO Stock Peers
BOSTONBIO Past Performance & Peer Comparison
BOSTONBIO Past Performance & Peer Comparison
Comparing 3 stocks from
FinancialsInvestment Banking & Brokerage
Compare valuation-basic on Screener
FinancialsInvestment Banking & Brokerage
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Boston Bio Systems Ltd | -9.29 | 0.79 | — |
| 360 One Wam Ltd | 47.54 | 13.99 | 0.45% |
| ICICI Securities Ltd | 15.01 | 7.43 | 2.66% |
| Angel One Ltd | 20.70 | 4.30 | 1.79% |
BOSTONBIO Stock Price Comparison
Compare BOSTONBIO with any stock or ETFCompare BOSTONBIO with any stock or ETF
BOSTONBIO
BOSTONBIO Holdings
BOSTONBIO Shareholdings
BOSTONBIO Promoter Holdings Trend
BOSTONBIO Promoter Holdings Trend
BOSTONBIO Institutional Holdings Trend
BOSTONBIO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
BOSTONBIO Shareholding Pattern
BOSTONBIO Shareholding Pattern
BOSTONBIO Shareholding History
BOSTONBIO Shareholding History
Foreign Institutions
smallcases containing BOSTONBIO stock
smallcases containing BOSTONBIO stock
Looks like this stock is not in any smallcase yet.
BOSTONBIO Events
BOSTONBIO Events
BOSTONBIO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BOSTONBIO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
BOSTONBIO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BOSTONBIO has not given any dividends in last 5 years
BOSTONBIO Dividends
BOSTONBIO Dividends
Hmm, looks like data is unavailable here. Please come back after some timeBOSTONBIO Stock News & Opinions
BOSTONBIO Stock News & Opinions
Articles & Videos
Earnings
Boston Bio Systems reports standalone net loss of Rs 0.49 crore in the March 2025 quarter
Net Loss of Boston Bio Systems reported to Rs 0.49 crore in the quarter ended March 2025 as against net loss of Rs 0.14 crore during the previous quarter ended March 2024. Sales reported to Rs 0.19 crore in the quarter ended March 2025. There were no Sales reported during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.55 crore in the year ended March 2025 as against net loss of Rs 0.14 crore during the previous year ended March 2024. Sales reported to Rs 0.19 crore in the year ended March 2025. There were no Sales reported during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales0.190 0 0.190 0 OPM %-257.890 --289.470 - PBDT-0.49-0.14 -250 -0.55-0.14 -293 PBT-0.49-0.14 -250 -0.55-0.14 -293 NP-0.49-0.14 -250 -0.55-0.14 -293 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Boston Bio Systems to discuss results
Boston Bio Systems will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant